115 related articles for article (PubMed ID: 5033956)
1. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
Hill GJ; Grage TB; Wilson W; Ansfield FJ
J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
[No Abstract] [Full Text] [Related]
2. Oral administration of fluorouracil. A preliminary trial.
Nadler SH
Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
[No Abstract] [Full Text] [Related]
3. Toxicity studies of fluorouracil used with adrenalectomy in breast cancer.
Piro AJ; Wilson RE; Hall TC; Aliapoulios MA; Nevinny HB; Moore FD
Arch Surg; 1972 Jul; 105(1):95-9. PubMed ID: 5031606
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy in gastrointestinal cancer.
Reitemeier RJ; Moertel CG; Hahn RG
Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
[No Abstract] [Full Text] [Related]
5. A clinical study of fluorouracil.
Nadler SH; Moore GE
Surg Gynecol Obstet; 1968 Dec; 127(6):1210-4. PubMed ID: 4882472
[No Abstract] [Full Text] [Related]
6. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
[No Abstract] [Full Text] [Related]
7. Experience with ftorafur treatment in breast cancer.
Karev NI; Blokhina NG; Vozny EK; Pershin MP
Neoplasma; 1972; 19(4):347-50. PubMed ID: 5054534
[No Abstract] [Full Text] [Related]
8. Phase II evaluation of BCNU and 5-FU in gastrointestinal carcinomas.
Tormey DC; Gailani S; Leone L
Oncology; 1974; 29(3):244-8. PubMed ID: 4415043
[No Abstract] [Full Text] [Related]
9. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
[No Abstract] [Full Text] [Related]
10. Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.
DeConti RC; Kaplan SR; Papac RJ; Calabresi P
Cancer; 1973 Apr; 31(4):894-8. PubMed ID: 4267531
[No Abstract] [Full Text] [Related]
11. A controlled comparison of 5-fluoro-2'-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion.
Moertel CG; Reitemeier RJ; Hahn RG
Cancer Res; 1967 Mar; 27(3):549-52. PubMed ID: 4225560
[No Abstract] [Full Text] [Related]
12. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
Gailani S; Holland JF; Falkson G; Leone L; Burningham R; Larsen V
Cancer; 1972 May; 29(5):1308-13. PubMed ID: 4623252
[No Abstract] [Full Text] [Related]
13. A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas.
Moertel CG; Rubin J; O'Connell MJ; Schutt AJ; Wieand HS
J Clin Oncol; 1986 Jul; 4(7):1053-7. PubMed ID: 3014083
[TBL] [Abstract][Full Text] [Related]
14. The variability of individual tolerance to methotrexate in cancer patients.
Hansen HH; Selawry OS; Holland JF; McCall CB
Br J Cancer; 1971 Jun; 25(2):298-305. PubMed ID: 4256007
[TBL] [Abstract][Full Text] [Related]
15. [Toxicities associated with chemotherapy in colorectal cancer].
Ura T; Shirao K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
[No Abstract] [Full Text] [Related]
16. A controlled evaluation of 5-fluorouracil utilizing a single injection technique.
Ahmann DL; Moertel CG; Bisel HF; Hahn RG; Schutt AJ; Dines DE
Oncology; 1974; 29(2):166-71. PubMed ID: 4836677
[No Abstract] [Full Text] [Related]
17. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.
Caballero GA; Ausman RK; Quebbeman EJ
Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced breast carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
Chlebowski RT; Pugh RP; Weiner JM; Bateman JR
Cancer; 1981 Oct; 48(8):1711-4. PubMed ID: 7284972
[TBL] [Abstract][Full Text] [Related]
19. Basal-cell carcinoma. A case unmasked by systemic fluorouracil therapy.
Scialla SJ; Miskoff RA
JAMA; 1976 May; 235(22):2416-7. PubMed ID: 946650
[No Abstract] [Full Text] [Related]
20. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
